123 - iGlarLixi Effectively Reduces Residual Hyperglycemia in Patients with Type 2 Diabetes on Basal Insulin: A Post-Hoc Analysis From the LixiLan-L Study

Publication date: October 2018Source: Canadian Journal of Diabetes, Volume 42, Issue 5, SupplementAuthor(s): Francesco Giorgino, Ravi Retnakaran, Josep Vidal, Vanita Aroda, Aramesh Saremi, Minzhi Liu

Source: Canadian Journal of Diabetes - October 5, 2018 Category: Endocrinology Source Type: research